Micropace has again been recognised as a leading high-tech exporter for NSW by being nominated in the 2016 awards for the Health and Biotechnology category.
"The Premier's NSW Export Awards is an annual program which aims to recognise excellence in the export of goods and services by NSW business. The Awards acknowledge the important contribution of businesses to the economy through job creation and increased prosperity for the community and for the state...Winners will be announced at a prestigious gala presentation dinner on Wednesday 26 October 2016 at The Star, Pyrmont."
Micropace today announced the long-awaited release of its revolutionary SureTouch Software 4.0. This re-thinking of the classic EPS320 interface has been hailed by early users as a leap forward in ergonomics and usability for electrophysiological diagnostic stimulators and is based on over 14 years of global market feedback.
"... so far the staff comments have been unanimous regarding the revisions rendering the interface more intuitive and approachable (I fully agree with that)."
Said a leading researcher at a major New England US hospital.
The new software is designed with touch controls firmly in mind, reflecting the fact that EP technicians and doctors are technology consumers as well as professionals. The interface is redesigned with much larger touch zones, a tactile overlay for sightless location of key controls (StimLab only), and ultra-high contrast of all important features. It has also been reorganized for optimum workflow in the modern EP lab, and is fully retrocompatible with the keyboard hotkeys on all previous versions so retraining of lab staff isn't required.
The stimulator also comes with over 1 hour of brand new in-built training videos (click here to view) and multi-language User Instruction Manuals. Other enhancements include an improved HFS protocol for GP ablation support, improved PPI protocol, a permanent voltage display, and the ability to double-tap items to open their parameters.
According to a trainer at a major multi-site, leading EP hospital in the US, "The staff liked that the interface was both simple and easy to use and the fellows were “ooo’ing” and “aaa’ing” at the various protocols I showed them."
All of these improvements come with the same legendary Micropace reliability, performance, and value. The new software is distributed worldwide on Micropace's StimLab, StimCor, and EPS320 stimulators by Boston Scientific Corporation and GE Healthcare.
Micropace celebrated its total export revenues of $45 Million with being awarded the Premier's NSW Export Award, Western Sydney, 2013.
The prize was presented by Charbel Geagea of Kelly + Partners (holding), accepted by Richard Savoie, Dr Michael Cejnar and Ms Dai Phan of Micropace
Ian Murray, Executive Chairman of the Export Council of Australia said "The Premier’s NSW Export Awards showcased the state’s best of the best exporters, in front of an audience of over six hundred guests and Guest of Honour the Hon Andrew Stoner, Deputy Premier of NSW. This year’s awards showcased some truly innovative companies, particularly in all export sectors and we congratulate MicroPace on their success.
The Export Council of Australia has announced that Micropace is a Finalist in the 2013 Premier's NSW Export Awards. The awards showcase the best and brightest exporters, who are making moves in new markets and expanding the export footprint of NSW. Micropace will be in attendence at the Award Ceremony on 16th October to hopefully bring home the trophy as a 2013 winner and move on to the National Finals.
Executive Chairman of The Export Council of Australia, Ian Murray stated, "It is great to see some impressive new entries this year and learn about their successes. This year is an exciting year for the Export Awards, with some brand new categories being introduced and, yet again, NSW did not disappoint. Companies saw great results from trading both with emerging markets and established markets. We wish the 2013 finalists the best of luck for the awards presentation on the 16th October at the Sydney Conference & Exhibition Centre, Darling Harbour"
Micropace reports nearly 100% year over year sales growth in China for EPS320 Family of products. Rapid market growth and largely increased gov't healthcare funding seen to be accelerating this market, which Micropace is well-positioned to grow in.
Micropace releases new extended European offerings including the NE (New Europe), BA (Baltic), and Iberian configurations. For details including the countries specified in each configuration, download a Micropace catalogue or contact us directly.